Peanut allergy blood test study
Part of Immune system & allergy clinical trials.
This study is testing a new blood test for peanut allergy. If you join, you will give a few extra blood samples during a regular blood draw. The test may help doctors better diagnose peanut allergies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already having blood drawn for any reason.
- You are willing to give two extra small tubes of blood (about 3ml each).
- You (or your legal guardian) can sign a consent form.
- You have not had immunotherapy (allergy shots or drops) for peanuts or other allergens.
- You have not taken certain steroids or immune-suppressing medications recently.
- You are not currently in another allergy treatment research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood (or uses already-collected blood) to learn why peanut, tree nut, and related food allergies happen and how they behave during challenges. It may help researchers better understand allergies and improve future care.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This study tests a new medication called LP-003 that may help people with peanut allergy tolerate peanuts better. If you qualify, you might receive the drug or a placebo, and researchers will see if it reduces allergic reactions to peanuts.
This study aims to identify markers in the blood that could help predict how severe a peanut allergy reaction might be. If you qualify, your child will undergo a supervised peanut challenge to see how their body responds.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
Hear when a new Peanut Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.